Double immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Double immunotherapy, covering 2024-02-13 to 2024-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment [Phase 2]